Drug Profile
Meningococcal polysaccharide vaccine groups ACYW135 - Hualan Biological Engineering
Latest Information Update: 27 Aug 2012
Price :
$50
*
At a glance
- Originator Hualan Biological Engineering
- Class Conjugate vaccines; Meningococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections
Most Recent Events
- 06 Dec 2011 Launched for Meningococcal group A infections in China (SC)
- 06 Dec 2011 Launched for Meningococcal group C infections in China (SC)
- 06 Dec 2011 Launched for Meningococcal group W-135 infections in China (SC)